SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

MapLight Therapeutics Q3 net loss widens 75% to $51.62 million

MapLight Therapeutics Q3 net loss widens 75% to $51.62 million MapLight Therapeutics’ third-quar

MPLT

Related stories